Search results
Results from the WOW.Com Content Network
The P-800 Oniks (Russian: П-800 Оникс; English: Onyx), marketed in export as the Yakhont (Russian: Яхонт; English: ruby), is a Soviet/Russian supersonic anti-ship cruise missile developed by NPO Mashinostroyeniya as a ramjet version of P-80 Zubr.
Currituck County Regional Airport [1] [2] [3] (ICAO: KONX, FAA LID: ONX, formerly 9W7) is a county-owned, public-use airport in Currituck County, North Carolina, United States. [1] It is located four nautical miles (5 mi , 7 km ) south of the central business district of Currituck, North Carolina . [ 1 ]
The Open Neural Network Exchange (ONNX) [ˈɒnɪks] [2] is an open-source artificial intelligence ecosystem [3] of technology companies and research organizations that establish open standards for representing machine learning algorithms and software tools to promote innovation and collaboration in the AI sector.
The VTX graphics subsystem is a cost reduced version of the RealityEngine2, using the same hardware but in a feature reduced configuration that can not be upgraded. It consists of one GE10 board (6 Intel i860XP processors vs 12 in RE2), a single RM4 or RM5 board, and a DG2 board.
Schwartz founded Onex in 1984 and took the company public in 1987. [2]In June 2007, General Motors sold Allison Transmission to financial investors Carlyle Group and Onex Corporation.
In April 2021, Dana Walden first mentioned the existence of a new BIPOC-focused programming initiative at Disney General Entertainment Content and Hulu. [4] Following the official launch of the brand on May 17, 2021, Onyx announced a number of upcoming projects produced by notable black creators including Questlove, Oprah Winfrey, and Prentice Penny. [5]
In addition to these disease types, there are scenarios. Plague Inc gives you the Fake News, Ultimate Boardgames, Science Denial, Mad Cow Disease, and The Black Death scenarios for free. However, all other scenarios cost $0.99 each. You can also buy a scenario pack, giving you all the scenarios for $2.99.
Oprozomib [1] (codenamed ONX 0912 and PR-047) is an orally active second-generation proteasome inhibitor developed by Proteolix, which was acquired by Onyx Pharmaceuticals, an Amgen subsidiary, in 2009. It selectively inhibits chymotrypsin-like activity of both the constitutive proteasome and immunoproteasome . [2]